Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce ...

Virtus LifeSci Biotech Clinical Trials ETF BBC is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 138.3% from its 52-week low price of $13.42/share.

Making its debut on 06/19/2006, smart beta exchange traded fund First Trust NYSE Arca Biotechnology ETF (FBT) provides investors broad exposure to the Health Care ETFs category of the market.What Are ...

BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.

The VanEck Biotech ETF (BBH) provides market-cap-weighted exposure to leading U.S.-listed biotechnology firms.

Biopharma has finally begun catching up with the overall stock market, as shares of the top three biopharma exchange traded funds (ETFs) jumped well into double digits over the past six months.

Biotech ETFs have had a banner year, earning some investors returns north of 30 percent since January. I say “some investors” because, it turns out, not all biotech ETFs are created equal. In our 2012 ...

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, they give sector participants exposure to many biotech companies via one ...

iShares Biotechnology ETF (NASDAQ:IBB) - $0.0828. Payable Sep 19; for shareholders of record Sep 16; ex-div Sep 16. BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH Biotech Looks ...

Bank of New York Mellon Corp trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 6.2% during the first quarter, HoldingsChannel.com reports. The institutional investor ...